Document Page: First | Prev | Next | All | Image | This Release | Search

File: 970101_sep96_decls3_0001.txt
Page: 0001
Total Pages: 1

Subject: CONVULSION ANTIDOTE FOR NERVE AGENT EXPOSURE 22 SEP 90          

Unit: VAR. BUMED  

Parent Organization: BUMED       

Box  ID: BX303814

Folder Title: FOLDER 12  VARIOUS NAVAL MESSAGES  SEC 1 OF 2                                                   

Document Number:         14

Folder Seq  #:         13


                  .......              UNCLASSIFIED
                                                ARLINGTON ANNEX
                                                MESSAGE CENTER

         IMMEDIATE                               ZYUW RULSBUA8805 2650200
         0 22020OZ SEP 90 ZYB
         FM BUMED WASHINGTON DC//02C//
         TO   USCINCCENT//CCSG//                 COMUSNAVCENT
              COMUSMARCENT                       COMUSNAVLOGSUPFOR//45//
              MEOTRE FAC COMFORT                 MEDTRE FAC MERCY
              CINCLANTFLT NORFOLK VA//N91C//
              CINCP.ACFLT PEARL HARBOR HI//45//
              CG FIRST FSSG                      CG I MEF
              CTG'ONE FIVE ZERO PT SIX
         INFO CNO WASHINGTON DC//932//           CMC WASHINGTON DC//MED//
              COMUSNAVCENT PEARL HARBOR HI//JJJ//
              USCINCCENT REAR MACDILL AFB FL//CCSG//

         UNCLAS //NO3403//
         SUBJ: CONVULSION ANTIDOTE FOR NERVE AGENT EXPOSURE
         OPER/DESERT SHIELD//
         MSGID/GENADMIN/BUMED//
         RMKS/1. THE CHEMICAL WARFARE RERVE AGENTS MAY CAUSE, IN ADDITION TO//
         PROBLEMS WITH NERVE TRANSMISSION, CONVULSIONS AND BRAIN DAMAGE. AN
         ANTI-CONVULSANT IS REQUIRED TO PREVENT OR AMELIORATE CONVULSIONS IN
         SEVERE NERVE AGENT CASULATIES. PRIMATE STUDIES HAVE DEMONSTRATED
         THAT DIAZEPAM CAN PREVENT OR ABATE SOMAN-INDUCED CONVULSIONS.
         DOCTRINE FOR USE OF AN ANTI-DOTE FOR CONVULSIONS HAS BEEN DEVELOPED.
         2. CONVULSANT ANTIDOTE NERVE AGENT (CANA) HAS BEEN PROCURED AND IS
         SCHEDULED FOR SHIPMENT TO THE AOR IN THE NEAR TERM. CANA IS PREPARED
         AS A 10 MG SOLUTION OF DIAZEPAM IN AN AUTOINJECTOR. CLINICAL DATA
         INDICATE THAT INTRAMUSCULAR INJECTION IN THE THIGH IS GENERALLY NOT
         PAINFUL AND ABSORPTION IS PROMPT AND CONSISTENT.
         3. DOCTRINE FOR USE OF THE CANA:
            A. CANA IS NOT, REPEAT NOT, FOR SELF AID. IT IS BUDDY AID.

         AND WILL BE CARRIED WITH HIS ISSUE OF ATROPINE AND 2-PAM CHLORIDE
         AUTOINJECTORS.
            C. THE BUDDY WILL ADMINISTER ONE CANA WITH THE CASUALTY'S THIRD
         ATROPINE INJECTOR OR IF THE CASUALTY IS HAVING CONVULSIONS.
            D. SEVERE NERVE AGENT POISONING MAY REQUIRE MULTIPLE 10 MG DOSES
         TO CONTROL CONTINUING CONVULSIONS, TO BE GIVEN AT 5 TO 10 MINUTE
         INTERVALS, FOR A TOTAL OF 3 INJECTIONS (30 MG DIAZEPAM). THE SECOND
         AND THIRD INJECTIONS WILL BE ADMINISTERED BY THE CORPSMAN.
            E. INJECTING 10 MG DIAZEPAM TO AN INDIVIDUAL WHO HAS ABSORBED NO
         NERVE AGENT WILL PRODUCE SIGNIFICANT PERFORMANCE DECREMENTS FOR 2 TO
         5 HOURS. HE WILL HAVE IMPAIRED VISUAL AND DECISION MAKING FUNCTIONS
         FOR FIVE HOURS.
            F. ANY CASUALTY REQUIRING CANA MUST BE MOVED TO REAR ECHELON
         CARE AS THE SYSTEM WILL ALLOW. EACH SPENT CANA AUTOINJECTOR MUST BE
         ATTACHED TO THE CASUALTY'S OUTER GARMENT WITH THE SPENT ATROPINE AND
         2-PAM CHLORIDE INJECTORS.
         3. CURRENT PLANS FOR TRAINING INCLUDE AN (N-THEATER TEAM FROM THE
         ARMY MEDICAL INSTITUTE OF CHEMICAL DEFENSE. RECOMMEND COORDINATION
         THROUGH CENTCOM MEDICAL OFFICE.
         4. MBRS OF BWF DISEASE/BW DIAGNOSTIC LAB STAFF CARRYING DRAFT COPIES
         OF U.S. ARMY DOCTRINE PROPOSALS FOR ALCON IN THEATRE.
         5. My POC IS CDR RICK WOLF, MSC, USN AT DSN 294-1333 OR
         (301) 653-1333.//
         6. MINIMIZE CONSIDERED. RELEASED BY CDR. HARRIS, MSC, USN.
         BT



         CMC WASH DC                                                   ADV     20
         COG    MED (1)                                         (U,8,F)
         INFO   I NT (2) P (1) PL (1) SO-L I C (1) ml (3) MI SSO (1) NAHO (1)
                POC(L) PO(l) POR(L) NMPCERC(L) NMPC01E(l) NMPC4(2)
                TFK CX (1) AtiRD (7)

                        MCN=90265/10748  TOR=90265/OGIGZ  TAD=90265/0633Z CDSN=MAX144
                          PAGE 1 OF 1
                                                                                  22020OZ SEP 90
                                      UNCLASSIFIED

Document Page: First | Prev | Next | All | Image | This Release | Search


Document 1 f:/Week-37/BX303814/FOLDER 12 VARIOUS NAVAL MESSAGES SEC 1 OF 2/convulsion antidote for nerve agent exposure 22 :1224960906494
Control Fields 17
File Room = sep96_declassified
File Cabinet = Week-37
Box ID = BX303814
Unit = VAR. BUMED
Parent Organization = BUMED
Folder Title = FOLDER 12 VARIOUS NAVAL MESSAGES SEC 1 OF 2
Folder Seq # = 13
Subject = CONVULSION ANTIDOTE FOR NERVE AGENT EXPOSURE 22
Document Seq # = 14
Document Date =
Scan Date =
Queued for Declassification = 01-JAN-1980
Short Term Referral = 01-JAN-1980
Long Term Referral = 01-JAN-1980
Permanent Referral = 01-JAN-1980
Non-Health Related Document = 01-JAN-1980
Declassified = 24-DEC-1996